Phase II Trial of RC1416 Injection in Asthma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Trial of RC1416 Injection in Asthma	Moderate to Severe Asthma	Recruiting	Phase 2	2026-09-10		NCT07403487

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Nanjing RegeneCore Biotech Co., Ltd.	3

44 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hangzhou First People's Hospital	Hangzhou	China	2
Anqiing Municipal Hospital	Anqing	China	1
Anyang People's Hospital	Anyang	China	6
Chengdu Fifth People's Hospital	Chengdu	China	9
Chengdu Third People's Hospital	Chengdu	China	2
China-Japan Friendship Hospital	Beijing	China	81
Daqing Oilfield General Hospital	Daqing	China	7
Gansu Provincial People's Hospital	Lanzhou	China	7
Heze Municipal Hospital	Heze	China	5
Huhhot First Hospital	Hohhot	China	1
Jilin Central Hospital	Jilin City	China	1
Mianyang Central Hospital	Mianyang	China	11
Nanjing Jiangning Hospital	Nanjing	China	2
Ningxia Hui Autonomous Region People's Hospital	Yinchuan	China	1
Qilu Second Hospital of Shandong University	Jinan	China	1
Qingdao Municipal Hospital	Qingdao	China	10
Sanmenxia Central Hospital	Sanmenxia	China	8
Shanghai Pulmonary Hospital (Tongji University Affiliated Shanghai Pulmonary Hospital)	Shanghai	China	1
Shengjing Hospital Of China Medical University	Shenyang	China	54
The Affiliated Hospital of Inner Mongolia	Hohhot	China	1
The Affiliated Hospital of Jining Medical University	Jining	China	1
The Affiliated Hospital of North China University of Science and Technology	Tangshan	China	2
The Affiliated Hospital of Xuzhou Medical University	Xuzhou	China	15
The Affiliated Yongchuan Hospital of Chongqing Medical University	Chongqing	China	2
The First Affiliated Hospital of Hebei North University	Zhangjiakou	China	2

Clinical trials